跳至主要内容
临床试验/ACTRN12605000550606
ACTRN12605000550606招募中3 期

Evaluation of new drug treatments including artemisinin combination therapy for uncomplicated malaria in children in Papua New Guinea

niversity of Western Australia0 个研究点目标入组 600 人开始时间: 2005年9月29日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
600

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
4 Years 至 10 Years(—)
性别
All

入选标准

  • Children with a history of fever and a blood film positive for either P. falciparum or P. vivax will be eligible provided that: i) they have no features of severe malaria,34 ii) there is no history of prior antimalarial drug use (quinine or artemisinin drugs within 7 days, or a 4-aminoquinoline, pyrimethamine and/or sulphonamide within 28 days), iii) there is no clinical evidence of another infection as a cause of fever, and iv) the childs parents or relatives give informed consent.

排除标准

  • No exclusion criteria

研究者

发起方
niversity of Western Australia

相似试验